Religo
January 19, 2024
Introduction:
Are you ready to witness the future of drug discovery? Imagine a world where advanced technology can unlock novel protein targets, explore unexplored chemical space, and accelerate the development of life-saving medicines.
Introducing Genesis Therapeutics, an AI-powered platform that harnesses the power of molecular AI to revolutionize drug discovery and development. With cutting-edge techniques like 3D spatial graph modeling and molecular simulation, our platform generates innovative drug candidates that have the potential to transform patient outcomes.
Backed by a team of experienced drug hunters, deep learning researchers, and software engineers, Genesis Therapeutics is dedicated to applying AI in biochemistry to discover and develop therapies for severe disorders. Our sophisticated AI technology has garnered attention from the press and received substantial investments, including a recent oversubscribed $200 million Series B funding round.
Through strategic partnerships with industry giants like Eli Lilly, Roche, and Genentech, we have gained recognition and support within the biotech community. Genesis Therapeutics is at the forefront of AI-driven drug discovery, utilizing advanced techniques and collaborations to accelerate the development of critical new medicines for the benefit of patients worldwide.
Overview:
Genesis Therapeutics is an AI-powered drug discovery platform that utilizes advanced molecular AI technology to unlock novel protein targets, explore unexplored chemical space, and accelerate the development of new medicines. The company’s platform combines cutting-edge techniques such as 3D spatial graph modeling and molecular simulation to generate innovative drug candidates.
With a team consisting of experienced drug hunters, deep learning researchers, and software engineers, Genesis Therapeutics is focused on applying AI in biochemistry to discover and develop therapies for patients suffering from severe disorders.
By leveraging its sophisticated AI technology, Genesis Therapeutics aims to revolutionize the field of biotech and drug discovery. The company has garnered significant attention in the press and has received substantial investments, including a recent oversubscribed $200 million Series B funding round.
Genesis Therapeutics has also formed strategic partnerships with industry giants like Eli Lilly, Roche, and Genentech, showcasing the recognition and support it has received within the biotech community.
Overall, Genesis Therapeutics is a pioneering company at the forefront of AI-driven drug discovery, utilizing advanced techniques and collaborations to accelerate the development of critical new medicines for the benefit of patients worldwide.
Benefits:
- Utilizes advanced molecular AI technology to unlock novel protein targets
- Explores unexplored chemical space
- Accelerates the development of new medicines
- Combines cutting-edge techniques such as 3D spatial graph modeling and molecular simulation
- Revolutionizes the field of biotech and drug discovery
Get Exclusive AI Tips right in your inbox!
Receive the same AI tips that helped me to make $37,605 in just two weeks!
We promise we won’t spam your inbox.
